Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Alberto Nieri"'
Autor:
Giulia Ferrarazzo, Alberto Nieri, Emma Firpo, Andrea Rattaro, Alessandro Mignone, Flavio Guasone, Augusto Manzara, Giuseppe Perniciaro, Stefano Spinaci
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 8703-8719 (2023)
Background: In clinically node-positive (cN+) breast cancer (BC) patients who become clinically node-negative (cN0) following neoadjuvant chemotherapy (NACT), sentinel lymph node biopsy (SLNB) after lymphatic mapping with lymphoscintigraphy is not wi
Externí odkaz:
https://doaj.org/article/0f66c7ab75d84f87824088f6e22669f6
Autor:
Alberto Nieri, Luca Urso, Matteo Caracciolo, Maria Ciccone, Licia Uccelli, Corrado Cittanti, Antonio Cuneo, Mirco Bartolomei
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 11, Iss 2, Pp 171-174 (2023)
Hodgkin Lymphoma (HL) is a malignancy involving lymph nodes and lymphatic system. [18F]F-FDG PET/CT (FDG-PET) imaging is routinely used for staging, to assess early chemotherapy response (interim FDG-PET), at the end of treatment (EoT FDG-PET) and fo
Externí odkaz:
https://doaj.org/article/682a07be22cc4da38470e899e9d2d8f1
Autor:
Luca Urso, Alberto Nieri, Licia Uccelli, Angelo Castello, Paolo Artioli, Corrado Cittanti, Maria Cristina Marzola, Luigia Florimonte, Massimo Castellani, Sergio Bissoli, Francesca Porto, Alessandra Boschi, Laura Evangelista, Mirco Bartolomei
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1110 (2023)
Lutathera® is the first EMA- and FDA-approved radiopharmaceutical for radioligand therapy (RLT). Currently, on the legacy of the NETTER1 trial, only adult patients with progressive unresectable somatostatin receptor (SSTR) positive gastroenteropancr
Externí odkaz:
https://doaj.org/article/378435a6c4914f93a56c7b538e6a105f
Autor:
Luca Urso, Angelo Castello, Giorgio Treglia, Stefano Panareo, Alberto Nieri, Ilaria Rambaldi, Matteo Caracciolo, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei
Publikováno v:
Diagnostics, Vol 13, Iss 4, p 606 (2023)
Background: this study aims to explore the prognostic and predictive role of volumetric parameters on [68Ga]Ga-DOTATOC PET/CT in neuroendocrine tumors (NET) patients treated with peptide receptor radionuclide therapy (PRRT). Methods: We retrospective
Externí odkaz:
https://doaj.org/article/cb69224df43f496d9c0bfaeafb6b3b1c
Autor:
Licia Uccelli, Alessandra Boschi, Corrado Cittanti, Petra Martini, Stefano Panareo, Eugenia Tonini, Alberto Nieri, Luca Urso, Matteo Caracciolo, Luca Lodi, Aldo Carnevale, Melchiore Giganti, Mirco Bartolomei
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1463 (2021)
The PRRT (Peptide Receptor Radionuclide Therapy) is a promising modality treatment for patients with inoperable or metastatic neuroendocrine tumors (NETs). Progression-free survival (PFS) and overall survival (OS) of these patients are favorably comp
Externí odkaz:
https://doaj.org/article/b1b42471cce24fc68e60f22c0da3d3ba
Autor:
Matteo Bauckneht, Silvia Morbelli, Francesco Fiz, Giulia Ferrarazzo, Roberta Piva, Alberto Nieri, Matteo Sarocchi, Paolo Spallarossa, Maria Elisa Canepari, Eleonora Arboscello, Andrea Bellodi, Massimo Massaia, Andrea Gallamini, Paolo Bruzzi, Cecilia Marini, Gianmario Sambuceti
Publikováno v:
Diagnostics, Vol 7, Iss 4, p 57 (2017)
Purpose: To verify the capability of 18F-fluorodeoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT) to identify patients at higher risk of developing doxorubicin (DXR)-induced cardiotoxicity, using a score-based image approach.
Externí odkaz:
https://doaj.org/article/fe28c16edb7d4786a52047ac7d26d389
Autor:
Luca Urso, Alberto Nieri, Ilaria Rambaldi, Angelo Castello, Licia Uccelli, Corrado Cittanti, Stefano Panareo, Irene Gagliardi, Maria Rosaria Ambrosio, Maria Chiara Zatelli, Mirco Bartolomei
Publikováno v:
Endocrine. 78:255-261
In the last 10 years, several literature reports supported radioligand therapy (RLT) in neoadjuvant settings for pancreatic neuroendocrine tumors (PanNETs). Indeed, primary tumor shrinkage has been frequently reported following RLT in unresectable or
Autor:
Luca Urso, Giovanni Christian Rocca, Grazia Maria Conti, Alessandro Colella, Alberto Nieri, Corrado Cittanti, Carmelo Ippolito, Mirco Bartolomei
Publikováno v:
Nuclear Medicine and Molecular Imaging.
Publikováno v:
Clinical Nuclear Medicine.
Autor:
Luca, Urso, Laura, Evangelista, Pierpaolo, Alongi, Natale, Quartuccio, Corrado, Cittanti, Ilaria, Rambaldi, Naima, Ortolan, Francesca, Borgia, Alberto, Nieri, Licia, Uccelli, Alessio, Schirone, Stefano, Panareo, Gaspare, Arnone, Mirco, Bartolomei
Publikováno v:
Cancers. 14(23)
Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) is a strong prognostic factor in breast cancer (BC). The aim of this study was to investigate whether semiquantitative parameters derived from baseline [